Envetec Sustainable Technologies
Shannonside Business Park
Co. Tipperary
V94 W30P
Ireland

+ 353 (0) 61 379 596

info@envetec.com

Benefits of Our
Technology

Envetec Insight

Can The Life Sciences Industry
Really Build a Circular Plastics Economy?

By Isabella Woodstock, Executive & Marketing Assistant

Single-use plastics are essential in the life sciences sector because they guarantee vital safety, sterility, and contamination control during critical research and manufacturing processes. They act as a necessary barrier that protects researchers, patients, and the integrity of scientific data from potential harm.

From standard laboratories to advanced pharmaceutical manufacturing, products such as pipettes, sample tubes, and petri dishes play a foundational role. However, their reliance creates a significant environmental challenge. Once these materials serve their purpose, they are almost exclusively treated as disposable waste rather than a reservoir of valuable materials. With the pharmaceutical industry alone estimated to produce up to 300 million tonnes of plastic waste annually, structuring a circular economy is a critical step towards offsetting this massive environmental footprint. The core challenge is not eliminating these plastics, but transforming how the industry treats them post-use to turn waste back into value.

What is the difference between a linear and a circular plastics model?

A linear model follows a “make, use, and dispose” pattern where valuable materials are permanently lost, whereas a circular model recovers and processes these materials to serve as the starting point for new products. By keeping high-value polymers in continuous use, a circular economy dramatically reduces the demand for virgin plastic production.

Historically, the life sciences industry has operated with a single-use mindset. Once a pipette tip or petri dish is used, standard clinical waste collection typically routes these items straight into disposal streams where their inherent material value is destroyed. Moving towards a circular model disrupts this single-use mindset. By recovering robust polymers like polypropylene and polyethylene, the industry can drastically reduce its heavy reliance on fossil fuels. The key to this transition is developing recovery pathways that capture material value without ever compromising the strict safety and performance standards required by laboratories.

How does traditional disposal prevent circularity?

Traditional disposal methods rely on extreme heat to destroy potential pathogens, which physically warps, melts, and degrades plastic polymers until they are impossible to recover. To achieve true circularity, the industry must move away from these destructive thermal processes.

Because of the severe infection risks involved, a vast majority of laboratory refuse is legally classified as biohazardous waste. To neutralise pathogens, traditional waste treatment heavily relies on extreme thermal processes like autoclaving or incineration. Consequently, many established biohazardous waste treatment companies use these high-temperature methods to ensure safety. Likewise, most regulated waste treatment companies employ similar thermal destruction techniques to manage biomedical waste, effectively destroying any chance of retaining the plastic’s original value.

The role of non-thermal technologies in creating sustainable solutions

To overcome these barriers, the industry must look towards innovative, non-thermal alternatives. Technologies like GENERATIONS support the shift towards circularity by shredding and disinfecting materials without heat. This preserves the structural integrity of the polymers and finally enables genuine biohazardous waste recycling. By safely maintaining the material’s value post-use, this breakthrough paves the way for scalable, highly effective waste recycling within the life sciences sector.

What steps are required to build a circular plastics economy?

Building a circular plastics economy requires a collaborative, multi-step approach that spans from the initial design of laboratory consumables to the deployment of non-thermal recovery systems. Every stakeholder across the supply chain must participate to keep materials in a continuous loop.

To successfully restructure the single-use mindset, the industry must implement the following steps:

  • Designing for Circularity: Products must be designed with end-of-life recovery in mind, ensuring they can easily transition from disposable items to recyclable ones.
  • Sustainable Procurement: Procurement teams can accelerate this shift by prioritising suppliers who champion circular design and sustainable manufacturing programmes.
  • Proper Segregation: Implementing strict waste classification ensures that recoverable materials are safely identified, separated, and routed to the correct recovery streams.
  • Innovative Processing: Adopting non-thermal treatment solutions that disinfect without degrading the underlying plastic polymers.

Can the Life Sciences Build a Circular Economy?

The life sciences industry absolutely can build a circular plastics economy, and many leading organisations are actively investing in these practices today. Because single-use plastics provide irreplaceable safety and sterility benefits, they will remain a staple in laboratories for the foreseeable future. Therefore, the greatest opportunity lies not in eliminating these crucial tools, but in entirely rethinking what happens to them after their initial use.

By designing products with circularity in mind, improving waste segregation, and investing in non-thermal recovery technologies, the sector can stop treating highly engineered polymers as garbage. Through long-term collaboration across the entire value chain, the life sciences industry can successfully move away from a linear model where plastics are simply disposed of, transforming them instead into sustainable, ongoing resources.

Isabella Woodstock, Executive & Marketing Assistant
Isabella Woodstock, Executive & Marketing Assistant

Let's Talk